Endocyte taps Nihon Medi-Physics in vintafolide-linked diagnostic deal
This article was originally published in Clinica
Executive Summary
The rise of targeted therapies is requiring the ever closer entwining of drugs and diagnostics along with new types of alliances to meet development and market needs, Endocyte's new partnership in Japan being a good example.